Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03
Published July 19, 2023 · Recall initiated: June 27, 2023
Summary
FDA records drug Class III recall D-0899-2023, published July 19, 2023 and initiated June 27, 2023. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 3,096 bottles; Lot: Lot #: A102887, Exp. 6/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
What to do
Voluntary: Firm initiated · Letter
Get an email if AMLODIPINE BESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMLODIPINE BESYLATE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed directly to three distributors in TN and NJ. Product may have been further distributed throughout the United States.
- UPC
- 0368180233022
- Lot
- Lot #: A102887, Exp. 6/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%), 0.5 FL OZJuly 19, 2023
- FDAAllergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), andJuly 19, 2023
- FDAOriginal Eye Drops; Redness Reliever; (Tetrahydrozoline HCl), 0.05%, 0.5 FL OZ (15mL); distributed by a)July 19, 2023
- FDAAmlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa,October 17, 2018
- FDAAMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd.,September 20, 2017
- FDAAmlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila HealthcareDecember 3, 2014
Questions about this recall
Was Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03 recalled?
Yes. FDA published recall D-0899-2023 on July 19, 2023. Reported hazard: Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMLODIPINE BESYLATE. UPC: 0368180233022.